Arkios BioDevelopment International
is a full service global biopharmaceutical consulting group providing contract research services (CRO) to emerging technology companies developing new drugs, biologics, medical devices, and diagnostics.

Arkios focuses on assisting emerging biopharmaceutical and device companies with the early stages of regulatory strategic planning process and implementation as well as in the filing of a successful Investigational New Drug/Investigational Device Exemption (IND/IDE) with the FDA.

We also design and manage the clinical development of emerging technologies in the biopharmaceutical and device area through successful product out-licensing or registration.

ARKIOS Can Serve You With:
• Outsourcing a specific clinical trial management function.
• Comprehensive regulatory affairs assistance.
• Data management & biostatistics
• Recruiting clinical research sites..
• Seeking early stage product development guidance in approaching the FDA.